TherapeuticsMD, Inc. (TXMD) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$3.0M

Net Income/Loss (FY2025)

-$569.0K

Total Assets (FY2025)

$37.7M

Total Equity (FY2025)

$26.9M

Cash Flows from Operating Activities (FY2025)

$2.5M

Source: TherapeuticsMD, Inc. 10-K/A filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.